Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting Lugano, Switzerland, March 18, 2021 – Helsinn, a Swiss pharmaceutical group focused on...